Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
Background: The presence of actionable alterations in advanced biliary tract cancer patients opened new therapeutic possibilities for second-line treatments. However, for around 60% of the patients, chemotherapy remains the only therapeutic option. The aim of our study was to evaluate outcomes and p...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2023-11-01
|
| Serier: | Life |
| Fag: | |
| Online adgang: | https://www.mdpi.com/2075-1729/13/11/2170 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
